At CTS, we understand the impact converting to the Ortho viral marker platform has on your operations. As we get closer to our implementation date of January 11, 2021 we are committed to providing you information as it becomes available.
Package inserts for the new assays are now available. You can review them on the Communications page by clicking this link: Communications,
On January 25, 2021, CTS implements the Ortho VIP viral marker testing platform. Conversion from the...
On July 6, 2018 the FDA released an industry guidance document for transitioning from individual to ...
We sincerely hope to see you at this year’s AABB Annual Meeting in San Antonio, TX on October ...
CTS originally communicated that Tampa will convert from the current Grifols Ultrio Plus NAT triplex...
In 2016, the Procleix Panther instrument was introduced by Grifols in support of automated NAT ZIKA ...
Honor Your StaffCelebrate Lab Week, and honor yourself and your colleagues as a vital part of the la...